Date Range
Date Range
Date Range
Chronicles of the Depressed Dog. although I do actually stalk. What? Do you think I am that. Morally challenged to do such a thing to my neighbours? Why the long face? On a wet November.
Friday, August 14, 2009. Anyway, I am here for some clarification. Yeah, I am not blogging anymore,. But I have another new one. I have at least 5 personal blogs in total but in the end I abandoned all of them.
Among the sea of memories, fishes of happiness and sadness swim freely. Tuesday, April 20, 2010. Thursday, April 15, 2010. It marks the end of the lectures. The date was 15th of April, 2001. The last lecture by Dr. Alan signified the end of my Biotechnology degree lessons, UTAR. Alan did not make it sound like one, but I know I have to accept the fact. The fact that I still sleep through the last lecture.
Maaf, sudah lama tidak berupdate! Posted by BIOTECH 072-082. Owh, before that I want to wish Salam Ramadhan to all biotech students. hopefully our Ramadhan this year will bring great experience to our lives. These icons link to social bookmarking sites where readers can share and discover new web pages. 30 October 2010 - Instrumentation in Biotechnology Research. 230 pm at Exam Hall Medicine.
Pondremos en tela de juicio lo que concierne a las madres de alquiler y la biotecnología. Alternativa al no poder ser mamá. 10 junio 2009 - Leave a Response. O común y malamente conocida como. La maternidad subrogada sabemos que consiste en la participación de una mujer que accede a gestar en su vientre a un niño, para más tarde dárselo a aquellos que hayan solicitado dichos servicios a cambio de una compensación económica.
A Look into The Future of Biotechnology. BIOTECH100 - CLASS A STOCK INDEX. 100 SMALL BIOTECHNOLOGY STOCKS WITH EMPHASIS IN DEVELOPMENT OF SMALL MOLECULE DRUGS THAT HAVE ONE OR MORE PRODUCTS CURRENTLY IN PHASE II OR PHASE III. BIOTECH100 - CLASS B STOCK INDEX. DRUGS IN CLINICAL TRIALS FOR THE BIOTECH100 INDEX.
Friday, October 14, 2011. I love the how the PR people put spins on data. Health care giant Johnson and Johnson likely will discuss its pipeline, recent drug approvals and several important deals when it reports its third-quarter results before the stock market opens Tuesday. The company may OR NOT! Give updates on several pending deals.
Quinta-feira, 19 de maio de 2011.